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Rural and urban differences in health
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Kee Seng Chia1, Peter C. Smith5,6, Rifat Atun7,8 and John Tayu Lee2,9
Abstract
Background: Despite improvement in health outcomes over the past few decades, China still experiences striking
rural-urban health inequalities. There is limited research on the rural-urban differences in health system performance
in China.
Method: We conducted a cross-sectional analysis to compare health system performance between rural and urban
areas in five key domains of the health system: effectiveness, cost, access, patient-centredness and equity, using
data from the WHO Study on Global AGEing and adult health (SAGE), China. Multiple logistic and linear regression
models were used to assess the first four domains, adjusting for individual characteristics, and a relative index of
inequality (RII) was used to measure the equity domain.
Findings: Compared to urban areas, rural areas had poorer performance in the management and control of hypertension
and diabetes, with more than 50% lower odds of having breast (AOR = 0.44; 95% CI: 0.30, 0.64) and cervical cancer screening
(AOR= 0.49; 95% CI: 0.29, 0.83). There was better performance in rural areas in the patient-centredness domain, with more
than twice higher odds of getting prompt attention, respect, clarity of the communication with health provider and
involvement in decision making of the treatment in inpatient care (AOR = 2.56, 2.15, 2.28, 2.28). Although rural residents
incurred relatively less out-of-pocket expenditures (OOPE) for outpatient and inpatient services than urban residents, they
were more likely to incur catastrophic expenditures on health (AOR = 1.30; 95% CI 1.16, 1.44). Wealth inequality was found in
many indicators related to the effectiveness, costs and access domains in both rural and urban areas. Rural areas had greater
inequalities in the management of hypertension and coverage of cervical cancer (RII = 7.45 vs 1.64).
Conclusion: Our findings suggest that urban areas have achieved better prevention and management of non-
communicable disease than rural areas, but access to healthcare was equivalent. A better understanding of the causes of the
observed variations is needed to develop appropriate policy interventions which address these disparities.
Keywords: Health system performance, Health systems, Rural-urban disparity, Health policy, China
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: mq.qin@u.nus.edu
1Saw Swee Hock School of Public Health, National University of Singapore,
Singapore, Singapore
Full list of author information is available at the end of the article
Qin et al. BMC Health Services Research          (2020) 20:372 
https://doi.org/10.1186/s12913-020-05194-6
Background
Since the economic liberalization which began in the
1980s, China has experienced rapid economic growth
(more than a 30-fold increase in gross national income
per capita from US$220 in 1980 to US$8690 in 2017, at
current US$) and improvements in health outcomes (aver-
age life expectancy at birth increased by more than 8 years
in 2015) [1, 2]. However, these national averages obscure
gross rural-urban inequities in outcomes [3, 4]. Compared
to urban areas, under-5 mortality was more than twice
higher (12.9 vs 5.8 per 1000 livebirths) in rural areas in
2015 [1, 5] The observed inequities between rural and
urban areas in health outcomes may be linked to the dif-
ferent performance of the health system [6–11].
The government of China, via its Healthy China 2030
Plan and through a series of far-reaching health reforms,
[12, 13] has set a bold vision for achieving universal
health coverage (UHC) and reducing health inequalities.
While almost the entire Chinese population (around 1.2
billion, over 95%) is currently covered by one of the
three major social health insurance schemes (the urban
employee basic medical insurance (UEBMI) scheme, the
urban resident basic medical insurance (URBMI)
scheme, and the new cooperative medical scheme
(NCMS)), [4, 14] low levels of service coverage and high
out-of-pocket expenditures have raised concerns about
lack of financial protection for patients with major long-
term health conditions. To ensure equitable access to
health services, since 2014, social health insurance re-
forms have been focusing on transforming from dual to
integrated health insurance system [15]. This includes
long-term efforts at vertical consolidation (rural NCMS
and urban URBMI and UEBMI) and horizontal consoli-
dation (fund pools and benefit packages) [15, 16].
Understanding rural-urban differences in health system
performance in China received increasing focus along with
the policy initiative of UHC [17]. In China, inequalities be-
tween rural and urban areas may be exacerbated due to
the residency control that further restricts population
mobilization and deters cross-region access health care
[10, 18]. Given the differences of China’s health system
across regions, understanding variation in health system
performance between rural and urban areas in China is
highly relevant not only to identify areas of relatively good
and poor performance, but also for improving resource al-
location and for the development of effective and targeted
policy interventions [19, 20]. This study aims to assess
rural-urban differences in health system performance
across a list of key indicators for elderly in China.
Methods
Sample and data
We used cross-sectional data from the World Health
Organization (WHO) Study on Global Ageing and Adult
Health (SAGE, wave 1). SAGE China adopted a stratified
multistage cluster sampling strategy to generate the sam-
ple. The survey primarily includes a nationally represen-
tative cohort of persons aged 50 years and above, with a
smaller cohort of persons aged 18 to 49 for comparison
purposes [21]. In brief, the aim of the SAGE is to under-
stand disability, healthcare utilisation and subjective
well-being of adult populations to inform evidence based
policy making. Rural/urban division was defined
throughout the sampling process by SAGE. More details
on the SAGE China sampling methods and assessment
have been described elsewhere [22].
The sample size consists of a total of 15,050 adults
aged 18 years and above from 10,278 households [22].
Our analysis was conducted based on the sample of re-
spondents aged 50 years and older, which included the
majority of the study population. The only exceptions to
this were the analyses of breast and cervical cancer
screening coverage, which comprised women in the
appropriate age ranges for cancer screening, i.e. 50–74
years old for breast screening, and aged 25–69 years for
cervical screening programs [23].
Analytical framework and health system performance
indicators
Our analyses adopted the health system framework from
Arah el al [24]. which considers five key performance
domains, including (a) effectiveness, (b) access, (c)
patient-centredness, (d) cost, and (e) equity. This frame-
work has been commonly used in other studies that
evaluate comparative health system performance across
countries [19, 24, 25]. A full list of the indicators and
definitions are presented in Additional file 1.
Effectiveness
In the effectiveness domain, we constructed eleven indi-
cators relating to the prevention and management of
common chronic conditions, in the areas of: (1) manage-
ment of hypertension; (2) management of diabetes; (3)
medical treatment for depression; (4) breast cancer
screening; (5) cervical cancer screening; (6) eye care; and
(7) dental care. Respondents self-reported the manage-
ment and prevention services of common chronic condi-
tions they received. In the case of hypertension,
respondents were considered to have hypertension if
they self-reported having a diagnosis of hypertension, or
if they had a mean systolic blood pressure of ≥140
mmHg or diastolic blood pressure of ≥90mmHg. Those
respondents identified as having hypertension, but not
self-reporting the condition, were defined as being
undiagnosed hypertensive. Controlled hypertension was
defined as those who had hypertension but having a
mean systolic blood pressure of ≤140 mmHg and dia-
stolic blood pressure of ≤90 mmHg.
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The assessment of coverage of cancer screening was
based on the responses to the following questions from
the SAGE: “When was the last time you had a mammog-
raphy?” and “When was the last time you had a pelvic
examination?” Respondents who answered positively for
pelvic examination were then asked: “The last time you
had a pelvic examination, did you have a Pap smear test?”
Following commonly used guidelines for breast and cer-
vical cancer screening in LMICs, coverage of breast cancer
screening was defined as the percentage of women aged
50–74 years old who had a mammography in the past 3
years, and coverage of cervical cancer screening was de-
fined as the percentage of women aged 25–69 years old
who had a pap smear in the past 3 years [23].
Cost
Indicators included in the cost domain for outpatient and
inpatient care were: 1) the percentage of respondents who
reported that their last visit was free; 2) the mean and me-
dian out-of-pocket expenditure (OOPE) amounts for their
last visit; 3) the percentage of OOPE by types of services
(i.e. healthcare provider fees, medicines, medical tests,
transport or other); 4) the proportion of households that
incurred catastrophic health expenditure (CHE). The first
three of these indicators were derived from individual
questionnaires, while the indicator for CHE was derived
from household questionnaires.
We defined a household as incurring CHE when
OOPE on health exceeded 20, 30%, or 40% or more of a
household’s capacity to pay [26]. Capacity to pay was de-
fined as total household expenditure minus subsistence
expenditure. To generate subsistence expenditure, the
mean of the per capita food expenditure (based on con-
sumption equivalents) of all households between the
45th and 55th percentiles of food as a share of total
household expenditure was used. The number of con-
sumption equivalents was calculated using a consump-
tion equivalence scale [27]. We removed household
observations for which their total household expenditure
was incomplete or equal to zero (5.3% of the sample
size). All monetary data are presented in local currency
Chinese Yuan.
Access
The access domain included: 1) the percentage of re-
spondents who received healthcare the last time it was
needed; 2) the percentage of respondents who indicated
that cost was a barrier to receiving healthcare; 3) the
proportion of respondents who received any outpatient
care in the last year or inpatient care in the past 3 years;
4) the number of inpatient and outpatient facilities vis-
ited last year; and 5) the proportion of respondents who
spent more than 1 h traveling to an outpatient clinic or
hospital.
Patient-Centredness
We included 10 indicators in the patient-centredness
domain for each of outpatient and inpatient care to as-
sess: 1) promptness of care; 2) being treated respectfully;
3) clarity of communication; 4) involvement in decision
making; 5) confidentiality; 6) choice of provider; 7) facil-
ity cleanliness; 8) overall satisfaction with care received;
9) health condition improvement following care; and 10)
achievement of expected outcome.
Responses for these indicators had five levels: 1 = very
good, 2 = good, 3 =moderate, 4 = bad, 5 = very bad, ex-
cept the response for 10) “achievement of expected out-
come”, which was a binary indicator (yes/no). The
ordinal responses were then dichotomized into “1” (if re-
sponse was “very good” or “good”) and 0 (if response
was “moderate” or “bad” or “very bad”).
Equity
We used the relative index of inequality (RII) [28] to
measure levels of socioeconomic equity (between the af-
fluent and deprived group) in health system performance
indicators in above four domains. RII measures the rela-
tive inequality, assuming a linear association between
the outcome indicators and ranked economic groups
[29, 30]. The value of RII farther away from 1 indicates a
larger inequality between the most affluent and the most
deprived population in the indicator assessed.
Statistical analysis
We summarized the mean or median for continuous in-
dicators, the proportion for categorical indicators in the
urban and rural areas, respectively. We used the
Kruskal-Wallis test (for continuous outcomes variable)
and the chi-square test (for binary outcome variables) to
compare characteristics between rural and urban re-
spondents. All statistical analyses were conducted using
STATA/ SE 14.0.
We used multiple logistic and linear regression models
for binary and continuous outcomes, respectively, to
assess the differences between urban and rural settings
across the first four domains. The numeric indicators in
the regression models were log-transformed to
normalize the distribution. Urban respondents were the
reference group for all analysis, and all regression
models run for the first four domains were adjusted for
socio-demographic variables (i.e. age, gender, education,
income quintile, marital status, insurance status and
province of residence). To obtain nationally representa-
tive estimates, all data analysis using individual or house-
hold level data was weighted to account for the complex,
multi-stage sampling strategy of the SAGE survey.
For the equity domain, we used RII to measure the
equity between the highest and lowest income group
within rural and urban areas respectively. We adopted
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the widely used Modified Poisson Regression model sug-
gested by Zou [31–33] to measure the relative difference
for the binary outcomes of interest. To calculate RII,
each income quintile was assigned a ridit score (ranging
from 0 to 1) as the explanatory variable. The ridit score
was the midpoint of ascending cumulative distribution
of each income group (lowest to highest income).
Results
Sample characteristics
A total of 13,271 respondents from 9650 households
were included in the study; 52.3% of the total sample
were rural dwellers, and 47.7% were urban dwellers.
Additional file 1 shows the sample flowchart for all out-
come variables. Compared to urban areas, rural areas
had a younger mean age (61.7 vs 63.5 years), lower per-
centage of female population (47% vs 54%), less educa-
tion attained (tertiary or higher: 0.1% vs 9.3%; primary
school or less: 80% vs 44.9%), and larger low-income
groups (the most affluent quintile: 8.6% vs 36%; the most
deprived quintile: 23.1% vs 8.8%). Appendix Table 1 pre-
sents the detailed sociodemographic characteristics of
the sampled population.
Effectiveness domain
Overall, respondents living in rural areas fared adversely
in nearly all indicators in the effectiveness domain com-
pared to respondents in urban areas (Table 1). The only
exception was in treatment of cataracts where a similar
proportion of patients in rural and urban areas had an
operation.
In the context of hypertension, the odds of having un-
diagnosed hypertension was higher among respondents
from rural areas than those living in urban areas (68.3%
vs 41.4%, AOR = 2.76; 95% CI: 2.35, 3.24). The odds of
taking prescribed medicines was lower in rural areas
compared with their urban counterparts (25.4% vs
52.9%, AOR = 0.33; 95% CI: 0.28, 0.39), and having
hypertension uncontrolled was 2.9 times more likely
(88.8% vs 68.8%; AOR = 2.94, 95% CI: 2.24, 3.86) than
the urban respondents.
For patients with diabetes, more respondents from
urban areas reported taking medication for their condi-
tions (85.3%) compared with their rural counterparts
(77.6%). In addition, rural residents had a lower adher-
ence (50.6% vs 74.6%, AOR = 0.37; 95% CI: 0.22, 0.62) to
a special diet and weight management to control blood
sugar levels than urban residents.
The proportion of women who had breast cancer
screening in the past 3 years was low in both rural
and urban areas (11.7% vs 26.8%), however, the rural
groups were less likely to have recommended levels
of breast cancer screening compared to their urban
counterparts (AOR = 0.44, 95% CI: 0.30, 0.64). The
percentage of women who reported having pap
smears for cervical cancer screening was also at a low
level in rural and urban areas (18.2% vs 35.9%), how-
ever, women from rural areas were still less likely to
be screened than those from urban areas (AOR = 0.49;
95% CI: 0.29, 0.83).
Rural residents less frequently had eye examinations
(8.4% vs 29%; AOR = 0.26, 95% CI: 0.13, 0.53); operation
of cataracts was nonetheless comparable between
Table 1 Effectiveness domain indicators in rural and urban China
Effectiveness indicator Overall Urban (Ref) Rural AOR* (95% CI)
Undiagnosed hypertension (%) 56.2 41.4 68.3 2.76 (2.35, 3.24)
Take prescribed meds with known HT in the past 12 months (%) 37.8 52.9 25.4 0.33 (0.28, 0.39)
Hypertension uncontrolled (%) 79.8 68.8 88.8 2.94 (2.24, 3.86)
Take prescribed meds for diabetes in the past 12 months (%) 83.4 85.3 77.6 0.49 (0.21, 1.16)
Special diet/ weight control for diabetes (%) 67.6 74.6 50.6 0.37 (0.22, 0.62)
Take prescribed meds for depression in the past 12 months (%) 35.3 45.6 20.9 0.73 (0.05,10.47)
Breast screening coverage in the past three years (%) † 19.3 26.8 11.7 0.44 (0.30, 0.64)
Cervical screening coverage in the past three years (%) †† 27.5 35.9 18.2 0.49 (0.29, 0.83)
Eye examination in the past three years (%) 20.4 29.0 8.4 0.26 (0.13, 0.53)
Operation if have cataracts (%) 22.5 22.0 24.0 1.38 (0.83, 2.31)
Medication or treatment from a dentist in the past 12 months (%) 36.8 50.9 28.3 0.36 (0.23, 0.56)
†: Breast cancer screening covered women aged 50-74 years old;
††: Cervical cancer screening covered women aged 25-69 years old;
Urban is the reference group.
*All models adjusted for age, gender, education, income quintile, marital status, insurance status and province of residence;
Bold for significance level of 0.05;
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respondents from rural and urban areas. The odds of
having dental treatment for mouth or teeth problems
was 64% lower (28.3% vs 50.9%; AOR = 0.36, 95% CI:
0.23, 0.56) among rural residents compared to their
urban counterparts.
Cost domain
The proportion of participants who reported that their
last outpatient visit was free was lower in the rural than
in urban groups (6.3% vs 10.7%; AOR = 0.48, 95% CI:
0.28, 0.81) (Table 2). However, the mean OOPE for the
last outpatient visit for those who reported non-free care
was substantially higher in the urban than rural groups
(295 vs 139 Yuan; regression coefficient for the log-
linear model = − 0.57; 95% CI: − 0.85, − 0.28). In the
inpatient setting, while the proportion of participants
reporting free inpatient care for the last visit was com-
parable between rural and urban areas (3.5% vs 4.8%;
AOR = 0.92, 95% CI: 0.45, 1.90), mean OOPE for the last
inpatient visit remained higher in urban than rural areas
(6722 Yuan vs 4194 Yuan for rural residents; regression
coefficient for the log-linear model = − 0.38; 95% CI: −
0.69, − 0.06).
We found that the highest proportion of spending in
outpatient and inpatient settings was on medicines,
followed by spending on test and provider fees. The
rural groups spent a considerably higher proportion of
their OOPE on medicines for both outpatient (91.1% vs
69.5%) and inpatient visits (60.1% vs 48.6%), compared
to the urban groups.
Table 2 Healthcare costs domain indicators in rural and urban China
Cost indicator Overall Urban (Ref) Rural Regression coefficients*
Outpatient
The last outpatient visit was free (%) 8.2 10.7 6.3 0.48 (0.28, 0.81) a
Mean out-of-pocket spending (Yuan) 206 295 139 −0.57 (− 0.85, − 0.28) c
Median of out-of-pocket spending (Yuan) 60 100 36 NA
Type of spending as % of out-of-pocket expenditure
Provider fees 4.6 9.3 1.7 −0.08 (0.02) b
Medicines 82.7 69.5 91.1 0.28 (0.08) b
Test 8.3 13.0 5.2 −0.10 (0.03) b
Transport 2.9 4.7 1.8 −0.04 (0.02) b
Other 1.5 3.5 0.2 −0.05 (0.02) b
Inpatient
The last inpatient visit was free (%) 4.1 4.8 3.5 0.92 (0.45, 1.90) a
Mean out-of-pocket spending (Yuan) 5397 6722 4194 −0.38 (−0.69, − 0.06) c
Median of out-of-pocket spending (Yuan) 2000 2500 1800 NA
Type of spending as % of out-of-pocket expenditure
Provider fees 12.8 13.7 12.0 −0.02 (0.02) b
Medicines 55.2 48.6 60.1 0.13 (0.03) b
Test 18.2 20.4 16.5 −0.03 (0.02) b
Transport 3.2 5.1 1.7 −0.04 (0.01) b
Other 10.7 12.1 9.7 −0.02 (0.02) b
Catastrophic health expenditure (%)d
20% 37.3 37.3 37.4 1.30 (1.16, 1.44) a
30% 28.6 27.5 29.4 1.16 (1.04, 1.30) a
40% 21.9 19.9 23.6 1.08 (0.96, 1.23) a
Out-of-pocket spending was log-transformed to normalize its distribution and used in the regression model
Urban is the reference group
NA: not applicable
*All models adjusted for age, gender, education, income quintile, marital status, insurance status and province of residence;
Bold for significance level of 0.05;
a: Odds ratio with 95% confidence interval was presented
b: coefficient from linear-regression model with standard error was presented
c: coefficient from log-linear regression model with 95% confidence interval was presented
d: percentage of respondents from a household which incurred catastrophic health expenditure
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Households incurring CHE is considerably high in
both rural and urban areas (rural vs urban with the
threshold at 40, 30 and 20%: 21.4, 27.3 and 35.2% vs
20.6, 27.6 and 37.1%). Similarly, the percentage of indi-
vidual participants from households incurring CHE
ranged from 21.9 to 37.3%. Residents from the rural
areas were more likely to be in a household which en-
countered CHE than their urban counterparts when the
CHE threshold was set at 20% (AOR = 1.30; 95% CI:
1.16, 1.44) and 30% (AOR = 1.16, 95% CI: 1.04, 1.30) of
the household’s capacity to pay.
Access domain
This domain evaluated access to outpatient and in-
patient care in three aspects (Table 3). Despite the ma-
jority of respondents reporting receiving care when
needed (95.2% in rural areas; 93.7% in urban areas), a
substantial proportion of participants reported cost as a
barrier to accessing healthcare (20.6% in rural areas and
26.0% in urban areas).
The number of outpatient visits was higher in urban
than rural areas (6.3 visits vs 4.6 visits in the last year re-
spectively). However, this difference in number of out-
patient visits was not statistically significant (P > 0.05)
after regression analysis adjusting for covariates.
Only a small proportion of patients from both rural
and urban areas spent more than 1 h traveling to the
clinic (3.0% vs 2.2%). The number of hospital stays were
comparably short in both rural and urban residents (0.18
vs 0.19 in the last year respectively), however, a substan-
tially higher (13.6% vs 1.2%, AOR = 9.34, 95% CI: 3.67,
23.77) percentage of respondents from rural area
reported spending more than 1 h travelling to a hospital
for inpatient care, compared to the urban population.
Patient-centredness domain
Among all indicators considered, the proportion of re-
spondents who reported better outcomes in patient-
centredness (i.e. “very good” or “good” rating) was over-
all higher in rural than urban areas (average value of all
indicators: 84% vs 82% for outpatient setting; 86% vs
77% for inpatient setting) (Table 4).
In the outpatient setting, responsiveness was mostly
comparable between rural and urban areas, except two
indicators where rural areas performed better: prompt
attention to get health service (AOR = 1.69, 95% CI:
1.16, 2.44); and satisfaction with the care received
(AOR = 1.53, 95% CI: 1.05, 2.21).
In the inpatient setting, respondents in rural areas per-
ceived better patient-centredness for most indicators
compared to their urban counterparts, except for one in-
dicator which was comparable. Compared to urban re-
spondents, the odds of giving a positive rating among
rural respondents was more than twice higher than
urban respondents in four aspects: prompt attention to
patient (AOR = 2.56, 95% CI: 1.53, 4.29), respectfulness
to patient (AOR = 2.15, 95% CI: 1.23, 3.77), patient in-
volvement in decision making for treatment (AOR =
2.28, 95% CI: 1.39, 3.74) and clearer communication
with healthcare providers (AOR = 2.28, 95% CI: 1.27,
4.11). Rural areas also had better performance regarding
clean facilities (AOR = 1.97), satisfaction with inpatient
care (AOR = 1.81), confidentiality of consultation
(AOR = 1.78) and choice of care provider (AOR = 1.76).
Table 3 Healthcare access domain indicators in rural and urban China
Access indicator Overall Urban (Ref) Rural Regression coefficient*
Received healthcare last time when needed (%) 94.5 93.7 95.2 1.15 (0.75, 1.78) a
Cost was a barrier to get healthcare (%) 23.5 26.0 20.6 0.82 (0.36, 1.87) a
Outpatient
Any outpatient visits in the past 12 months (%) 60.2 56.8 63.3 1.25 (0.95, 1.64) a
Number of outpatient visits in the past 12 months 5.3 6.3 4.6 −0.18 (0.10) b
How long it took you to get to the clinic (% > 1 h) 2.6 2.2 3.0 0.89 (0.36, 2.34) a
Inpatient
Any hospital stays in the past 3 years (%) 22.2 22.5 21.8 0.93 (0.75, 1.16) a
Length of hospital stays in the past 12 months 0.18 0.19 0.18 −0.02 (0.02) b
How long it took you to get to the hospital (% > 1 h) 7.2 1.2 13.6 9.34 (3.67, 23.77) a
Number of outpatient visits and hospital stays were log-transformed to normalize its distribution and used in the regression model
Urban is the reference group;
*All models adjusted for age, gender, education, income quintile, marital status, insurance status and province of residence;
Bold for significance level of 0.05;
a: regression coefficient represents the adjusted odds ratio (AOR) from the logistic model
b: regression coefficient represents the results from linear-regression model
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A considerable percentage of respondents in rural and
urban areas reported their health condition getting bet-
ter as expected after outpatient and inpatient care. The
odds of achieving the expected outcome from inpatient
care was 1.73 (95% CI: 1.03, 2.90) times higher among
rural than urban residents.
Equity domain
Pro-rich inequalities were observed in many effective-
ness indicators (Table 5). For example, the RII for the
rate of undiagnosed hypertension was less than 1 in both
rural and urban areas, indicating that this measure was
lower for those with greater wealth. The RII was greater
than 1 for rates of breast and cervical screening cover-
age, indicating that these measures were greater among
those with greater wealth.
In indicators for the effectiveness domain, inequal-
ities were wider for rural respondents compared to
urban respondents in the following indicators: (a)
taking prescribed medicines with known hypertension
(RII = 1.62, 95% CI: 1.21, 2.18 vs RII = 1.15, 95% CI:
0.98, 1.35); (b) undertaking breast cancer screening
(RII = 3.47, 95% CI: 1.74, 6.91 vs RII = 2.97, 95% CI:
1.66, 5.29); (c) having eye examination (RII = 2.83,
95% CI: 1.19, 6.73 vs RII = 2.26, 95% CI: 1.29, 3.96);
and (d) conducting cervical cancer screening (RII =
7.45 95% CI: 2.78, 19.95 vs RII = 1.64, 95% CI: 0.83–
3.22).
In the cost domain, both rural and urban areas had pro-
rich inequalities in the occurrence of CHE (threshold defined
from 20 to 40%: RII = 0.48–0.60 in rural; RII = 0.24–0.40 in
urban), indicating that the richer groups had lower risk of in-
curring CHE. The scale of wealth inequalities in the incur-
rence of CHE was wider among urban respondents than
rural respondents.
Inequality in access to healthcare was in general
smaller in rural than urban areas, including access to
healthcare when needed (RII = 1.03, 95% CI: 0.99, 1.07
vs RII = 1.11, 95% CI: 1.05, 1.17), outpatient visits in the
past 12 months (RII = 1.22, 95% CI: 0.98, 1.51 vs RII =
1.47, 95% CI:1.18, 1.83) and time to get to clinic > 1 h
(RII = 0.26, 95% CI: 0.09, 0.77 vs RII = 0.17, 95% CI:0.04,
Table 4 Patient-centredness domain indicators in rural and urban China
Patient-centredness indicator Overall Urban (Ref) Rural AOR* (95% CI)
Outpatient
Prompt attention 81.8 77.1 85.6 1.69 (1.16, 2.44)
Respect 85.7 83.9 87.0 1.67 (0.93, 1.77)
Clarity of communication 80.4 80.0 80.7 0.98 (0.73, 1.31)
Involvement in decision making 77.7 76.9 78.3 1.16 (0.84, 1.61)
Confidentiality 77.5 77.6 77.4 1.12 (0.82, 1.53)
Choice of provider 84.2 82.7 85.4 1.29 (0.89, 1.86)
Facility cleanliness 79.8 78.7 80.6 1.11 (0.77, 1.61)
Satisfaction 86.1 83.8 87.9 1.53 (1.05, 2.21)
Condition improved 90.0 89.6 90.4 1.24 (0.63, 1.89)
Outcome expected (%) 90.6 90.1 91.0 1.30 (0.83, 2.04)
Inpatient
Prompt attention 80.6 73.8 87.1 2.56 (1.53, 4.29)
Respect 82.0 77.1 86.8 2.15 (1.23, 3.77)
Clarity of communication 78.8 72.5 85.0 2.28 (1.27, 4.11)
Involvement in decision making 72.8 66.2 79.2 2.28 (1.39, 3.74)
Confidentiality 75.9 71.7 79.9 1.78 (1.12, 2.83)
Choice of provider 80.6 76.9 84.2 1.76 (1.04, 2.99)
Facility cleanliness 79.0 74.6 83.3 1.97 (1.24, 3.14)
Satisfaction 82.0 76.3 87.2 1.81 (1.16, 2.84)
Condition improved 92.6 91.7 93.5 1.31 (0.73, 2.35)
Outcome expected (%) 88.0 85.0 90.7 1.73 (1.03, 2.90)
Urban is the reference group;
*All models adjusted for age, gender, education, income quintile, marital status, insurance status and province of residence;
Bold for significance level of 0.05;
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0.75) / hospital > 1 h (RII = 0.60, 95% CI: 0.17, 2.1 vs
RII = 0.09, 95% CI: 0.01, 0.87). Nevertheless, inequality in
‘cost as a barrier to access to healthcare’ was comparably
large in both rural (RII = 0.15) and urban (RII = 0.14)
areas.
Perception of patient-centredness was in general simi-
lar among the richest and poorest population groups in
both rural and urban areas, except for a few indicators
showing statistically significant but minor inequalities
for the outpatient setting (Table 6): for example, the
widest pro-rich inequality was found in satisfaction with
outpatient care received in urban areas (RII = 1.26, 95%
CI: 1.11, 1.43).
Discussion
This study examined differences in health system per-
formance between rural and urban areas in China using
a large, nationally representative dataset of adults aged
50 years and older.
Our findings that the management and control of
hypertension and diabetes were worse in rural than
urban areas are consistent with recent studies in China.
The awareness, treatment and control of hypertension
[34, 35] and diabetes [16, 36, 37] were lower among pa-
tients from rural areas especially those with low income,
compared to those from urban areas. This is likely to be
due to differences in modifiable lifestyle factors (e.g.
Table 5 Equity domain indicators for effectiveness, cost and access in rural and urban China
Equity index RII∁ (95% CI) Absolute
difference
Urban Rural
Effectiveness
Undiagnosed hypertension 0.77 (0.65, 0.91) 0.83 (0.75, 0.92) 0.06
Take prescribed meds with known hypertension 1.15 (0.98, 1.35) 1.62 (1.21, 2.18) 0.47
Hypertension uncontrolled 1.01 (0.85, 1.20) 1.04 (0.97, 1.12) 0.03
Take prescribed meds for diabetes 0.99 (0.81, 1.20) 0.99 (0.76, 1.30) 0
Special diet/ weight control for diabetes 1.02 (0.81, 1.28) 0.64 (0.26, 1.58) −0.38
Take prescribed meds for depression 1.94 (0.40, 9.54) 1.89 (0.17, 21.34) −0.05
Breast screening coverage 2.97 (1.66, 5.29) 3.47 (1.74, 6.91) 0.5
Eye examination 2.26 (1.29, 3.96) 2.83 (1.19, 6.73) 0.57
Cervical screening coverage 1.64∘ (0.83, 3.22) 7.45 (2.78, 19.95) 5.81
Operation if have cataracts 0.85 (0.50, 1.43) 1.1 (0.35, 3.50) 0.25
Medication or treatment from a dentist 1.06 (0.68, 1.67) 1.23 (0.80, 1.89) 0.17
Cost
The last outpatient visit was free 1.92 (0.82, 4.52) 1.59 (0.85, 2.92) −0.33
The last inpatient visit was free 4.63 (0.88, 24.36) 4.89 (1.54, 14.73) 0.26
Catastrophic health expenditure
20% 0.40 (0.35, 0.46) 0.60 (0.51, 0.71) 0.2
30% 0.32 (0.26, 0.38) 0.52 (0.43, 0.63) 0.2
40% 0.24 (0.20, 0.29) 0.48 (0.39, 0.60) 0.24
Access
Received healthcare last time when needed 1.11 (1.05, 1.17) 1.03 (0.99, 1.07) −0.08
Cost was a barrier to getting healthcare 0.14 (0.06, 0.32) 0.15 (0.03, 0.92) 0.01
Any outpatient visits in the past 12 months 1.47 (1.18, 1.83) 1.22 (0.98, 1.51) −0.25
Time to get to the clinic> 1 h 0.17 (0.04, 0.75) 0.26 (0.09, 0.77) 0.09
Any hospital stays in the past 3 years 1.17 (0.84, 1.63) 1.11 (0.79, 1.56) −0.06
Time to get to the hospital> 1 h 0.09 (0.01, 0.87) 0.60 (0.17, 2.1) 0.51
RII= Relative Index of Inequality
∁: All measures adjusted for respondents’ age and gender unless stated
∘: means the result did not adjust for gender;
Bold for significance level of 0.05;
The lowest income group was the reference group with rural and urban areas;
Absolute difference was rural deducted by urban
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smoking, alcohol consumption, physical inactivity) asso-
ciated with hypertension, as well as the lower availability
of and higher costs to adhere to prescribed medicines
for hypertension among rural groups [34, 35, 38]. In
addition, as suggested by Liu et al., better self-awareness
of diabetes among urban residents may also lead to bet-
ter access to preventive health services and disease man-
agement than among rural residents [39].
Our findings indicated that while the coverage for
breast cancer and cervical cancer screening were poor
among eligible women in both rural and urban areas,
coverage was worse among those from rural areas and
for the poorest. Using data from the China Chronic Dis-
ease and Risk Factor Surveillance System (CCDRFSS),
Wang et al. (2013) consistently found a lower coverage
of breast cancer screening (mammography) [40] in rural
areas than urban areas in China. Another study by Wang
et al. (2015) also found the coverage of cervical cancer
screening (Papanicolaou test) lower in rural compared to
urban areas [41]. The disparity in screening coverage be-
tween rural and urban areas may reflect a range of social
and other factors that are detrimental to preventive ser-
vice use, including a level of disadvantage related to edu-
cational and employment opportunities, income, and
access to health services.
We also concluded that although rural residents
paid less OOPE for outpatient and inpatient services
than urban residents, people from rural areas were
still more likely to incur CHE. Previous findings on
rural-urban differences in financial protection and
healthcare access are mixed. Wang et al. (2016) and
Long et al. (2013) showed lower OOPE among rural
residents than urban residents, [42, 43] which is con-
sistent with our findings. When restricting the study
population to those with chronic conditions, however,
Jian et al. (2010) and Li et al. (2018) found that rural
Table 6 Equity domain indicators for patient-centredness in rural and urban China
Equity index RII∁ (95% CI) Absolute
difference
Urban Rural
Outpatient
Prompt attention 0.97 (0.84, 1.12) 1.00 (0.91, 1.12) 0.03
Respect 1.01 (0.92, 1.11) 1.01 (0.91, 1.12) 0
Clarity of communication 1.05 (0.95, 1.16) 1.05 (0.92, 1.20) 0
Involvement in decision making 1.19 (1.02, 1.40) 1.12 (1.00, 1.26) −0.07
Confidentiality 1.16 (0.98, 1.36) 1.15 (1.02, 1.31) −0.01
Choice of provider 1.10 (0.95, 1.28) 1.03 (0.91, 1.16) −0.07
Facility cleanliness 1.05 (0.89, 1.24) 1.16 (1.01, 1.34) 0.11
Satisfaction 1.26 (1.11, 1,43) 1.06 (0.99, 1.34) −0.2
Condition improved 1.02 (0.91, 1.16) 0.94 (0.89, 0.99) −0.08
Outcome expected 1.19 (1.11, 1.28) 1.01 (0.95, 1.07) −0.18
Inpatient
Prompt attention 0.92 (0.72, 1.18) 0.94 (0.82, 1.07) 0.02
Respect 1.02 (0.83, 1.25) 1.04 (0.92, 1.18) 0.02
Clarity of communication 0.95 (0.76, 1.20) 1.09 (0.92, 1.28) 0.14
Involvement in decision making 1.07 (0.86, 1.32) 1.07 (0.92, 1.24) 0
Confidentiality 1.00 (0.81, 1.25) 1.17 (0.98, 1.41) 0.17
Choice of provider 1.05 (0.81, 1.35) 1.03 (0.90, 1.19) −0.02
Facility cleanliness 1.08 (0.85, 1.37) 1.12 (0.88, 1.42) 0.04
Satisfaction 1.05 (0.84, 1.32) 1.10 (0.95, 1.25) 0.05
Condition improved 1.06 (0.97, 1.16) 1.04 (0.92, 1.17) −0.02
Outcome expected 1.11 (0.96, 1.28) 1.09 (0.95, 1.24) −0.02
RII= Relative Index of Inequality
∁: All measures adjusted for respondents’ age and gender unless stated
Bold for significance level of 0.05;
The lowest income group was the reference group with rural and urban areas;
Absolute difference was rural deducted by urban
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residents with chronic conditions had higher OOPE
compared to their urban counterparts [44, 45]. This
could be due to insufficient benefit coverage of the
rural health insurance schemes, where rural residents
with chronic conditions had to face higher co-
payment rates compared to urban counterparts [44].
Our findings on CHE were consistent with two previ-
ous studies at both national and provincial level,
where the occurrence of CHE was high in both rural
and urban areas and even higher among rural and the
poorest households [4, 46].
Our findings showing comparable health services use
between rural-urban respondents were supported by sev-
eral recent studies which showed gradual reduction in
the inequity of health care utilization since 1990s [4, 18,
44, 47]. This may be due to the rapid improvement in
public health insurance benefit coverage in the rural area
in China since the inception of the new rural co-
operative medical scheme in 2002 [18].
Our findings on patient centredness were similar to a
recent study (based on data from two provinces in
China) showing a higher patient satisfaction among rural
residents compared with urban residents who visited
the county-level hospitals in 2011 [48]. However, our
results were in contrast with another recently pub-
lished study that found higher outpatient satisfaction
among people who visited public hospitals in urban
areas than those seeking care in rural areas [49]. It is
suggested that the differences in benefit coverage of
various insurance plans contribute to the gaps in pa-
tients’ perspective of care [50].
Overall, our results indicate that significant gaps exist
between rural and urban areas in several key health sys-
tem indicators despite provision of almost universal
health insurance coverage. Our findings on rural-urban
differences in health system performance are generally
consistent with the existing literature [4, 47, 51]. Based
on a trend analysis, Meng et al. showed that patients in
rural areas tend to face greater risks of catastrophic
health expenditure and be less likely to be hospitalized
than urban areas [4]. In a review of evidence on the im-
pact of social health insurance (SHI) reforms on
patients, Liu et al. found that SHI reduced patients’ co-
payment rate and incentivized care-seeking at higher
level facilities and longer stays in hospital, whilst the im-
pact on out-of-pocket expenditures varied by rural and
urban areas [51].
Strengths and limitations
Our study has five important limitations. First, use of
self-reported measures of chronic disease and health-
care utilisation may underestimate the prevalence,
particularly for older persons and those from lower
socioeconomic and educational backgrounds who may
be more likely to under-report [52]. Second, while
SAGE is internationally recognised as one of the
highest quality sources to examine health outcomes
for the adult and elderly population, the SAGE ques-
tionnaire does not include information on other im-
portant health system performance indicators such as
reproductive, maternal, neonatal and child health ser-
vices. Third, poorer people (say in rural areas) may
have low OOPE because they do not seek access to
care due to financial barriers or seek care at lower
level health facilities that require lower cost. It is im-
portant to note that financial protection cannot be
discussed in isolation from access to care [53].
Fourth, some important indicators of health system
performance were unavailable from the survey data,
such as indicators for infectious disease outcomes. Fu-
ture studies should consider exploring a wider range
of indicators to reduce reporting bias and for health
system performance assessment, or incorporate sensi-
tivity analysis to assess the accuracy and validity of
the estimates when comparing two groups with differ-
ent socioeconomic characteristics [52]. Lastly, our
study is cross-sectional in design and is therefore un-
able to examine variation in rural-urban differences in
health system performance over time. Future studies
using pooled cross-sectional or longitudinal study de-
signs are warranted to monitor changes in rural-
urban comparisons.
Policy implications
China’s health system has made enormous progress to-
wards UHC since the 2000s, especially in rural areas and
western and central regions [51, 54]. This includes major
advances in reducing rural-urban inequalities in insur-
ance coverage, maternal and infant mortality rates, and
use of outpatient and inpatient care [4, 55]. However,
there are considerable concerns about the lack of em-
phasis given to health promotion and prevention of
chronic diseases, quality of healthcare services, efficiency
of service delivery and cost escalation [4, 56, 57].
This study reveals systematic differences in health
system performance between urban and rural areas in
China, with implications for equitable access to health
care. This is not surprising [47]. Strategies to move
towards UHC, especially in middle income countries
that have experienced rapid economic growth along-
side growing wealth inequalities, and rapid epidemio-
logical and demographic transitions, like China, must
manage a complex mix of patient demands and ex-
pectations, political acceptability of health system de-
velopment trajectories, and affordability of UHC.
UHC strategies that have been much lauded, such as
that of Thailand, have also structurally embedded
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inequalities [58]. The critical issue is the development
of strategy to reduce these inequalities over time.
One of the recent health reforms to tackle inequalities
to fulfil the government’s commitment of UHC by 2020
includes a consolidation of the rural (NCMS) and urban
(URBMI) social health insurance schemes [59]. SHI con-
solidation has been piloted in selected Chinese provinces
such as Tianjin, Shandong, Zhejiang and Guangdong in
eastern, Qinghai, Chongqing, Ningxia in western China
[15]. While national and provincial guidelines are needed
based on international and domestic experience, it is
essential to have political commitments that reinforce
political legitimacy, institutional innovations that over-
come structural deficiencies, and a feasible implementa-
tion plan that coordinates various local conditions,
financing capacity and benefit packages for a successful
consolidation of SHI [15, 60].
China will only be able to achieve these if it can
address the efficiency and cost escalation concerns in
its health system. For example, it will only be politic-
ally acceptable to more influential urban populations
to more fully cross-subsidise rural populations’ access
Appendix
Table 1 Characteristics of the sociodemographic variables of the sampled population
Characteristics All (n = 13,271) Urban (n = 6529) Rural (n = 6742) P value∫
Age, mean (SD) 62.5 (9.0) 63.5 (9.3) 61.7 (8.6) < 0.01
Age group in years, n (%) < 0.01
50–59 5766 (45.1) 2593 (40.5) 3137 (49.3)
60–69 3941 (31.8) 1894 (31.5) 2047 (31.9)
70–79 2784 (18.6) 1628 (23.1) 1156 (14.4)
80 and above 780 (4.6) 414 (4.9) 366 (4.4)
Gender, (%) < 0.01
Male 6241 (49.9) 2913 (46.4) 3328 (53.0)
Female 7030 (50.1) 3616 (53.6) 3414 (47.0)
Marital status, n (%) 0.38
Married/cohabiting 11,022 (85.1) 5408 (84.5) 5614 (85.7)
Single/separated/widowed 2249 (14.9) 1121 (15.5) 1128 (14.3)
Education, n (%) < 0.01
Primary school or less 8402 (63.3) 2753 (44.9) 5649 (80.0)
Secondary school 2595 (19.7) 1760 (45.7) 835 (19.9)
Tertiary or higher 2274 (17.0) 2016 (9.3) 258 (0.1)
Income quantile, n (%) < 0.01
Q1 (lowest) 2649 (16.3) 826 (8.8) 1823 (23.1)
Q2 2641 (18.2) 886 (11.1) 1755 (24.7)
Q3 2684 (20.6) 1371 (19.1) 1313 (21.9)
Q4 2719 (23.3) 1540 (25.1) 1179 (21.7)
Q5 (highest) 2578 (21.7) 1906 (36.0) 672 (8.6)
Health insurance coverage, n (%) 11,614 (89.6) 5164 (82.0) 6450 (96.6) < 0.01
Province, n (%) < 0.01
Guangdong 1566 (16.1) 780 (24.5) 786 (8.4)
Hubei 1568 (14.3) 797 (9.3) 771 (18.9)
Jilin 1686 (6.5) 830 (6.3) 856 (6.7)
Shanxi 1762 (9.0) 864 (7.0) 898 (10.9)
Shandong 1902 (25.2) 953 (21.9) 949 (28.2)
Shanghai 1774 (5.6) 820 (4.3) 954 (6.8)
Yunnan 1550 (9.8) 699 (11.9) 851 (8.0)
Zhejiang 1463 (13.4) 786 (14.9) 677 (12.1)
∫:
P-value was calculated using Kruskal-Wallis test for continuous variables and chi-square test for categorical variables
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to health care when the growing availability of re-
sources to the whole health system, together with re-
duction of wasteful use of resources, enables that to
be achieved without an appreciable reduction in ac-
cess to care in urban areas. Some strategies have been
developed to address these concerns such as the
“zero-mark-up” policy for essential drugs to control
cost escalation, and billions of government investment
in public health services especially in rural areas to
improve efficiency of resource allocation [61]. Further
extended health reforms that are embodied in Healthy
China 2030, a government blueprint, are needed to
meet the ongoing health problems such as chronic
diseases, an aging population, and rising expectations
of health [55, 62, 63]. The capacity of primary health-
care system needs further strengthened to manage the
rising burden of chronic diseases and health expendi-
tures [62].
Unequal development between rural and urban
areas in China is not an issue confined to the health
sector, and strategies to reduce health system inequal-
ities will need to be accompanied by reductions in so-
cial and economic inequalities. Unless services are
universally free, uptake of interventions such as breast
cancer screening will inevitably be affected by ability
to pay and wealth inequalities between rural and
urban areas will inevitably translate to rural-urban in-
equalities in the uptake of screening. Social inequal-
ities are also marked, and health professional staff
perceive a considerable gap between the social status
of those working in rural primary care and those
working in urban tertiary care [64, 65]. It is unlikely
that this perception can be much affected without
real changes in the social status of rural residents
which is currently institutionalised in the hukou sys-
tem. Hence the health sector will not be the sole
source of policies needed to reduce the inequalities
described in this data.
Conclusion
Using a nationally-representative dataset, our study was
one of the first to systematically examine rural-urban
differences across a list of key health system perform-
ance indicators. Our findings that urban areas have
achieved better prevention and management of non-
communicable disease than rural areas, but access to
healthcare was equivalent. Although rural residents in-
curred less out-of-pocket expenditures for outpatient
and inpatient services than urban residents, they were
more likely to have catastrophic expenditures on health.
Pro-rich inequalities were larger among rural areas than
urban areas in terms of hypertension management and
coverage of cancer screening. A better understanding of
the causes of the observed variations is needed to
develop appropriate policy interventions that address
these disparities.
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